Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits

Detalhes bibliográficos
Autor(a) principal: Liu, Shu-Qin
Data de Publicação: 2020
Outros Autores: Zhang, Li-Ping, Yan, Huan-Ying, Zhang, Xing-Hua, Wang, Le-Xin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/181831
Resumo: To assess the effect of nesiritide on the endothelial function of iliac arteries following endothelia trauma. Right iliac artery trauma was created with a balloon catheter. Ten rabbits were treated with a 4-week subcutaneous injection of nesiritide at a fixed daily dose of 0.1mg/kg. Ten rabbits received daily normal saline injection. Plasma endothelin 1 (ET-1), nitric oxide (NO), and Von Willebrand Factor (vWF) were measured before and after the therapies. Tissue proliferating cell nuclear antigen (PCNA) was measured after the treatment. After the treatment, in the therapeutic group, the area under internal elastic membrane and the residual lumen area were higher than in the normal saline group (P <0.05). The plasma levels of ET-1 (91.6±6.8 vs 114.9±6.3 ng/L, P =0.001), vWF (134.6±10.8% vs 188.8±10.4%, P =0.001) and the ratio of PCNA positive expression (11.7±4.2% vs 36.2±11.4%, P =0.005) in the therapeutic group was lower than in the normal saline group, while the plasma levels of NO was higher (89.7±9.3 vs 43.5±5.3 μmol/L, P =0.001). Nesiritide inhibited remodeling of rabbit iliac artery following endothelial trauma. The inhibition of vascular remodeling may be related to the alleviated endothelial dysfunction and reduced expression of tissue proliferating cell nuclear antigen.
id USP-31_f349a32038ca82dbb39b7c0060cbfcb5
oai_identifier_str oai:revistas.usp.br:article/181831
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbitsPlasma endothelin (ET-1)Nitric oxide (NO)von Willebrand Factor (vWF)Tissue proliferating cell nuclear antigenIliac arteryTo assess the effect of nesiritide on the endothelial function of iliac arteries following endothelia trauma. Right iliac artery trauma was created with a balloon catheter. Ten rabbits were treated with a 4-week subcutaneous injection of nesiritide at a fixed daily dose of 0.1mg/kg. Ten rabbits received daily normal saline injection. Plasma endothelin 1 (ET-1), nitric oxide (NO), and Von Willebrand Factor (vWF) were measured before and after the therapies. Tissue proliferating cell nuclear antigen (PCNA) was measured after the treatment. After the treatment, in the therapeutic group, the area under internal elastic membrane and the residual lumen area were higher than in the normal saline group (P <0.05). The plasma levels of ET-1 (91.6±6.8 vs 114.9±6.3 ng/L, P =0.001), vWF (134.6±10.8% vs 188.8±10.4%, P =0.001) and the ratio of PCNA positive expression (11.7±4.2% vs 36.2±11.4%, P =0.005) in the therapeutic group was lower than in the normal saline group, while the plasma levels of NO was higher (89.7±9.3 vs 43.5±5.3 μmol/L, P =0.001). Nesiritide inhibited remodeling of rabbit iliac artery following endothelial trauma. The inhibition of vascular remodeling may be related to the alleviated endothelial dysfunction and reduced expression of tissue proliferating cell nuclear antigen.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18183110.1590/s2175-97902019000418430Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18430Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18430Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e184302175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181831/168733Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLiu, Shu-Qin Zhang, Li-Ping Yan, Huan-Ying Zhang, Xing-Hua Wang, Le-Xin 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181831Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
title Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
spellingShingle Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
Liu, Shu-Qin
Plasma endothelin (ET-1)
Nitric oxide (NO)
von Willebrand Factor (vWF)
Tissue proliferating cell nuclear antigen
Iliac artery
title_short Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
title_full Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
title_fullStr Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
title_full_unstemmed Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
title_sort Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
author Liu, Shu-Qin
author_facet Liu, Shu-Qin
Zhang, Li-Ping
Yan, Huan-Ying
Zhang, Xing-Hua
Wang, Le-Xin
author_role author
author2 Zhang, Li-Ping
Yan, Huan-Ying
Zhang, Xing-Hua
Wang, Le-Xin
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Liu, Shu-Qin
Zhang, Li-Ping
Yan, Huan-Ying
Zhang, Xing-Hua
Wang, Le-Xin
dc.subject.por.fl_str_mv Plasma endothelin (ET-1)
Nitric oxide (NO)
von Willebrand Factor (vWF)
Tissue proliferating cell nuclear antigen
Iliac artery
topic Plasma endothelin (ET-1)
Nitric oxide (NO)
von Willebrand Factor (vWF)
Tissue proliferating cell nuclear antigen
Iliac artery
description To assess the effect of nesiritide on the endothelial function of iliac arteries following endothelia trauma. Right iliac artery trauma was created with a balloon catheter. Ten rabbits were treated with a 4-week subcutaneous injection of nesiritide at a fixed daily dose of 0.1mg/kg. Ten rabbits received daily normal saline injection. Plasma endothelin 1 (ET-1), nitric oxide (NO), and Von Willebrand Factor (vWF) were measured before and after the therapies. Tissue proliferating cell nuclear antigen (PCNA) was measured after the treatment. After the treatment, in the therapeutic group, the area under internal elastic membrane and the residual lumen area were higher than in the normal saline group (P <0.05). The plasma levels of ET-1 (91.6±6.8 vs 114.9±6.3 ng/L, P =0.001), vWF (134.6±10.8% vs 188.8±10.4%, P =0.001) and the ratio of PCNA positive expression (11.7±4.2% vs 36.2±11.4%, P =0.005) in the therapeutic group was lower than in the normal saline group, while the plasma levels of NO was higher (89.7±9.3 vs 43.5±5.3 μmol/L, P =0.001). Nesiritide inhibited remodeling of rabbit iliac artery following endothelial trauma. The inhibition of vascular remodeling may be related to the alleviated endothelial dysfunction and reduced expression of tissue proliferating cell nuclear antigen.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181831
10.1590/s2175-97902019000418430
url https://www.revistas.usp.br/bjps/article/view/181831
identifier_str_mv 10.1590/s2175-97902019000418430
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181831/168733
dc.rights.driver.fl_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18430
Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18430
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18430
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222915146285056